Deep Vein thrombosis Flashcards
Define Deep vein thrombosis
Development of a blood clot in a major deep vein in the leg, thigh, pelvis, or abdomen, resulting in impaired venous blood flow.
Aetiology of deep vein thrombosis
Virchow’s triad: Vessel injury, venous stasis, and activation of the clotting system
Thrombophilia
- ProteinC/S/AT-III deficiency
- Factor V Leiden
- Prothrombin mutation G20210A
- Anti-phospholipid syndrome
Risk factors for deep vein thrombosis
Increasing age
Pregnancy
Oestrogen products e.g. COCP, HRT
Trauma
Surgery, esp. orthopaedic
Previous DVT
Immobility: recent hospitalisation, long-haul flights
Active malignancy
Obesity
Epidemiology of DVT
Relatively common, yearly incidence of 1 in every 100 adults
2/3 of all cases of VTE is DVT, 1/3 PE
300,00 deaths per year arise due to VTE (mostly PE)
Incidence increases with age
Population incidence is increasing as it ages
Symptoms of DVT
Calf swelling
Tenderness (along deep venous system)
Mild fever
Signs of DVT on examination
Hot, swollen, red, tender calf
- Asymmetric oedema
- Prominent superficial veins
- Calf warmth and Erythema
- Difference of calf circumference >3cm → DVT likely (measured 10cm below the tibial tuberosity + 10-15 above upper edge of patella)
Localised pain along the deep venous system from groin to adductor and popliteal fossa
- Homan’s sign: tenderness with dorsiflexion of the foot
- Pratt’s sign: calf pain on palpation
Investigations for DVT
Calculate 2 level Well’s score
≥2
<4h → proximal vein US
→ +ve → start treatment
→ -ve → stop anti-coagulation → D-dimer
→ → D-dimer +ve → repeat US 1 week later
> 4h → D-dimer + start DOAC → US within 24h
<2
<4h → D-dimer + interim DOAC
→ +ve → proximal vein US (if -ve → rescan in 1 week)
→ -ve → stop DOAC, consider other diagnosis
Management for Deep vein thrombosis
DOAC: dabigatran, rivvaroxaban, apixaban, edoxaban
+ warfarin
→ renal impairment/cancer/pregnancy → LMWH/unfractionated heparin + warfarin
Continue anti-coagulation:
Provoked: 3 months
Unprovoked: 6 months
Conservative: TED stockings/pneumatic compression | encourage exercise
Active bleed → IVC filter
How are DOACs excreted and how can they be reversed
Excretion: DabigatRENAL, LIVERoxaban, AbPOOxaban
Dabigatran is the only reversible DOAC (with idarucizumab)
Complications of DVT
Pulmonary embolism
Post-phlebitic limb (chronic venous insufficiency)
Heparin-induced thrombocytopenia (stop and start argatroban/fondaparinux)
Bleeding
Heparin resistance
Heparin → osteoporosis
Prognosis for deep vein thrombosis
Most patients do not get VTE if on thromboprophylaxis.
Inadequate prophylaxis may lead to VTE
When a patient dues from DVT, it is usually from PE or from major haemorrhage as a complication of the anticoagulation.
30% of patients develop recurrent VTE between 6 months and 5 years after the initial event (off anticoagulants)